Approximately 60,012 bottles of Losartan Potassium (50 mg) tablets, distributed by The Kroger Co., are being recalled because trace amounts of a potentially cancer-causing impurity called NMBA were found in the active ingredient. This medication is used to treat high blood pressure and help protect the kidneys in patients with type 2 diabetes. While there are no reports of adverse health effects from this specific batch, long-term exposure to this impurity is considered a health risk. Consumers should check their prescription bottles immediately to see if their medication is part of the affected lot sold in Tennessee and Arizona.
The tablets contain trace amounts of N-Methylnitrosobutyric acid (NMBA), an impurity that is classified as a potential human carcinogen. Chronic exposure to this substance over a long period may increase the risk of developing cancer.
Consultation and Refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.